» Articles » PMID: 39526056

Dry Eye in Diabetes: The Indian Diabetic and Endocrine Eye Diseases (INDEED) Review

Overview
Specialty Endocrinology
Date 2024 Nov 11
PMID 39526056
Authors
Affiliations
Soon will be listed here.
Abstract

Dry eye disease (DED) is an inadequately addressed condition in the diabetes management process and can significantly impact the quality of life and self-care. Therefore, it was imperative to review DED in the diabetic population. The aim of this article was to obtain insights into the correlation between dry eye and diabetes, with a focus on data published in the Indian population. A comprehensive literature review was performed using MEDLINE and Google Scholar, along with an internet-based search of publicly available information and peer-reviewed publications that may not have been indexed in these databases. The recommendations from several important societies for patients with DED have also been reviewed. Major aspects commonly associated with DED and diabetes have been addressed, and specific suggestions for screening, diagnosis and treatment have been described. Therefore, this review could be an invaluable resource for doctors managing patients with both conditions.

References
1.
Kuo Y, Shao S, Lin E, Pan L, Yeung L, Sun C . Tear function in patients with diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022; 13:1036002. PMC: 9633841. DOI: 10.3389/fendo.2022.1036002. View

2.
Tong L, Lim L, Tan D, Heng W, Lim J, Chan C . Assessment and Management of Dry Eye Disease and Meibomian Gland Dysfunction: Providing a Singapore Framework. Asia Pac J Ophthalmol (Phila). 2021; 10(6):530-541. PMC: 8673856. DOI: 10.1097/APO.0000000000000417. View

3.
Sebai I, Chihaoui M, Elfeleh E, Oueslati I, Yazidi M, Chebbi A . [Diabetic papillopathy after intensification of insulin therapy: A case report]. Rev Med Interne. 2018; 40(3):188-190. DOI: 10.1016/j.revmed.2018.08.007. View

4.
Ahmad R, Mehta H . The ocular adverse effects of oral drugs. Aust Prescr. 2021; 44(4):129-136. PMC: 8377292. DOI: 10.18773/austprescr.2021.028. View

5.
Varadhan L, Humphreys T, Hariman C, Walker A, Varughese G . GLP-1 agonist treatment: implications for diabetic retinopathy screening. Diabetes Res Clin Pract. 2011; 94(3):e68-71. DOI: 10.1016/j.diabres.2011.08.017. View